Friday, July 12, 2024 10:37:56 PM
Recent KRON News
- Kronos Bio Reports Second Quarter 2024 Financial Results and Pipeline Update • GlobeNewswire Inc. • 08/08/2024 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:03:39 PM
- Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer • GlobeNewswire Inc. • 07/23/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 09:02:06 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:58:54 PM
- Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:15:00 PM
- Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events • GlobeNewswire Inc. • 05/22/2024 08:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2024 08:15:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 12:20:22 PM
- Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer • GlobeNewswire Inc. • 05/21/2024 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:08:31 PM
- Kronos Bio Reports First-Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/09/2024 08:05:00 PM
- Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 08:01:00 PM
- Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial Results • GlobeNewswire Inc. • 03/21/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:05:26 PM
- Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash Runway • GlobeNewswire Inc. • 03/07/2024 09:05:00 PM
- Kronos Bio To Present Three Posters at AACR 2024 Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:44:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 12:00:23 PM
- Kronos Bio Announces Participation in 44th Annual Cowen Health Care Conference • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:07:47 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:06:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:04:36 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:03:09 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 01:05:18 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM